Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3199 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2934 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-12-12 | 2020-03-12 | 101148 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107989 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-07-23 | 109565 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110661 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-03-25 | 2021-04-08 | 136304 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153144 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157268 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-04-28 | 2022-07-20 | 159578 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-06-09 | 2022-12-08 | 162274 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179291 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183377 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195222 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-20 | 2023-07-12 | 195839 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197507 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-13 | 2023-10-04 | 198602 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-08-03 | 2023-08-18 | 200873 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-10-05 | 2023-12-07 | 206371 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-01-18 | 2024-03-07 | 216457 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CAPTOPRIL | 25MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258556 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258759 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |